Trial Profile
An effect of belimumab on patients with active systemic lupus erythematosus (SLE).
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 28 Feb 2017 New trial record